HopeStage
Back to all studies
CompletedNCT02582905

Citicoline or Pregnenolone for Alcohol Use in Bipolarity

About this titleRead the official source — NCT02582905
Medication studyAges 18–70United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 70 years.

Listed locations
Miami and 2 more locationsSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: May 2016
Recruitment status
Completed
Enrollment listed in the registry
96
Sponsor
Sherwood Brown, MD, PhD
Sponsor type
Individual investigator
Study type
Drug
Intervention type
Dietary supplement, Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 18 Years to 70 Years
Official registry ID
NCT02582905
Official title
Show the full official title

Clinical Medication Development for Bipolar Disorder and Alcohol Use Disorders

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Miami · Dallas · Edinburg

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Sherwood Brown, MD, PhD.

Did this study involve medication?

Yes. The study involved medication, including Placebo and Pregnenolone.

Who was this study for?

Listed age limits: 18 years to 70 years.

Want to explore more studies?

Explore studies